Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
59.95
+0.05 (0.08%)
At close: Jun 27, 2025, 4:00 PM
59.04
-0.91 (-1.52%)
After-hours: Jun 27, 2025, 4:04 PM EDT
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $1.95 billion as of June 27, 2025. Its market cap has increased by 34.19% in one year.
Market Cap
1.95B
Enterprise Value
1.82B
1-Year Change
34.19%
Ranking
Category
Stock Price
$59.95
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $1.95B, an increase of 1,249.54%. That is a compound annual growth rate of 127.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 1.92B | -1.39% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 714.32B |
| Johnson & Johnson | 367.24B |
| AbbVie | 329.73B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 275.64B |
| Abbott Laboratories | 232.63B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |